external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus.
Explore the latest updates from the life science industry.

Featured Articles.

BIOTECH

Houdini Bio: tackling the gene-silencing barrier in genetic medicines

PHARMA

EyePoint’s DURAVYU misses first Phase 3 endpoint in wet AMD, putting focus on second trial

BIOTECH

Using Jumping Genes for Safer, More Accurate DNA Editing

BIOPROCESSING

Bio-Rad Expands Foresight Pro Chromatography Columns for Biomanufacturing

PHARMA

AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma

HEALTH

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

BIOTECH

Oxford and 2U Launch New Programme in AI-Driven Drug Discovery

PHARMA

How Automation is Accelerating Drug Discovery Timelines

BIOPROCESSING

Bioreactors and Cell Culture Media: A Practical Comparison for Upstream Bioprocessing

Latest News.

26th September, 2026

01. Big Picture Bio launches with £2.2m to develop AI-designed cancer combination therapies

London biotech Big Picture Bio launches with £2.2m to develop AI-designed cancer combination therapies using a generative world model and wet-lab validation.

24th September, 2026

02. BIOPLUS-INTERPHEX KOREA 2026 to Showcase Global Biotech Innovation, with Canada Named Country of Honor

BIOPLUS-INTERPHEX KOREA 2026 (BIX 2026), Korea’s largest biotechnology and pharmaceutical convention, will take place at COEX in Seoul from October 28–30.

18th September, 2026

03. Andelyn reaches commercial manufacturing milestone following FDA approval of Fayuvi

Andelyn Biosciences has reached a commercial manufacturing milestone following the U.S. Food and Drug Administration’s (FDA) approval of Ultragenyx Pharmaceutical’s Fayuvi™ gene therapy for Sanfilippo syndrome type A.

15th September, 2026

04. Fuse Diagnostics raises £1m to scale rapid molecular testing platform

Cambridge-based diagnostics company Fuse Diagnostics has secured £1 million in new funding to accelerate the commercialisation of its rapid, instrument-free molecular testing platform and expand manufacturing capacity in the UK.